Loading clinical trials...
Loading clinical trials...
Purpose:Retinopathy of prematurity (ROP) continues tobe a major cause of blindness in children. Although ablation of the retina with laser or cryotherapy reduces the incidence of blindness by suppress...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Asociación para Evitar la Ceguera en México
NCT07093255 · Retinopathy of Prematurity (ROP)
NCT06315556 · Retinopathy of Prematurity, Preterm Infants
NCT05558059 · Retinopathy of Prematurity
NCT06067958 · Retinopathy of Prematurity, Dexmedetomidine
NCT06694103 · Retinopathy of Prematurity (ROP)
Asociación para Evitar la Ceguera en México Hospital "Luis Sanchez Bulnes"
Mexico City, Mexico DF
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions